In addition, the serum GDF15 concentration is notably increased in patients with glioma, prostate, colorectal, or pancreatic cancers, and GDF15 was recently described as one of the 20 biomarkers that best define the malignant phenotype of numerous tumors 9,10,13. The gene discussed is GDF15; the disease is familial pancreatic carcinoma.